XML 1038 R29.htm IDEA: XBRL DOCUMENT v2.4.0.6
SCHEDULE II CONDENSED FINANCIAL INFORMATION OF REGISTRANT
12 Months Ended
Dec. 31, 2012
SCHEDULE II CONDENSED FINANCIAL INFORMATION OF REGISTRANT [Abstract]  
SCHEDULE II CONDENSED FINANCIAL INFORMATION OF REGISTRANT
SCHEDULE II
 
CONDENSED FINANCIAL INFORMATION OF REGISTRANT
 
        
Form 10-K
 
        
Baldwin & Lyons, Inc.
 
(Dollars in thousands)
 
        
Condensed Balance Sheets
      
   
December 31
 
   
2012
  
2011
 
Assets
      
Investment in subsidiaries
 $362,450  $334,328 
Due from affiliates
  2,719   5,282 
Investments other than subsidiaries:
        
Fixed maturities
  11,073   11,353 
Limited partnerships
  255   291 
    11,328   11,644 
Cash and cash equivalents
  12,134   5,690 
Accounts receivable
  8,033   5,890 
Other assets
  7,225   7,694 
Total assets
 $403,889  $370,528 
Liabilities and shareholders' equity
        
          
Liabilities:
        
Premiums payable
 $29,652  $26,367 
Deposits from insureds
  15,489   13,682 
Notes payable to bank
  10,000   10,000 
Current payable federal income taxes
  -   368 
Other liabilities
  2,036   1,050 
    57,177   51,467 
Shareholders' equity:
        
Common stock:
        
Class A
  112   112 
Class B
  524   522 
Additional paid-in capital
  50,275   48,751 
Unrealized net gains on investments
  35,467   26,592 
Retained earnings
  260,334   243,084 
    346,712   319,061 
          
Total liabilities and shareholders' equity
 $403,889  $370,528 
          
          
          
          
See notes to condensed financial statements
        

 
 
SCHEDULE II
 
CONDENSED FINANCIAL INFORMATION OF REGISTRANT
 
           
Form 10-K
 
           
Baldwin & Lyons, Inc.
 
(Dollars in thousands)
 
           
Condensed Statements of Operations
         
   
Year Ended December 31
 
   
2012
  
2011
  
2010
 
Revenue:
         
Commissions and service fees
 $20,753  $20,974  $21,913 
Dividends from subsidiaries
  14,000   14,000   15,000 
Net investment income
  48   100   135 
Net realized gains (losses) on investments
  (49)  67   (100)
Other
  24   98   284 
    34,776   35,239   37,232 
Expenses:
            
Salary and related items
  15,410   12,281   12,869 
Other
  7,098   5,550   5,615 
    22,508   17,831   18,484 
Income before federal income taxes
            
and equity in undistributed
            
income of subsidiaries
  12,268   17,408   18,748 
Federal income tax (benefit)
  (629)  1,004   1,195 
    12,897   16,404   17,553 
Equity in undistributed income (loss)
            
of subsidiaries
  19,022   (44,579)  7,462 
              
Net income (loss)
 $31,919  $(28,175) $25,015 

 
 
SCHEDULE II
CONDENSED FINANCIAL INFORMATION OF REGISTRANT
             
Form 10-K
             
Baldwin & Lyons, Inc.
(Dollars in thousands)
             
Condensed Statements of Cash Flows
           
   
Year Ended December 31
   
2012
 
2011
 
2010
             
Net cash provided by operating activities
 
$20,735
 
$13,255
 
$32,296
             
Investing activities:
           
Purchases of long-term investments
 
(8,944)
 
(10,025)
 
(10,889)
Sales or maturities of long-term investments
 
8,902
 
9,704
 
9,910
Decrease in notes receivable from employees
 
1,252
 
106
 
611
Distributions from limited partnerships
 
-
 
444
 
23
Net disposals (purchases) of property and equipment
 
(834)
 
(622)
 
413
Other
 
228
 
128
 
212
Net cash provided by (used in) investing activities
 
604
 
(265)
 
280
             
Financing activities:
           
Dividends paid to shareholders
 
(14,886)
 
(14,846)
 
(33,212)
Drawing on line of credit
 
-
 
-
 
8,000
Repayment on line of credit
 
-
 
(5,000)
 
(3,000)
Net cash used in financing activities
 
(14,886)
 
(19,846)
 
(28,212)
Increase (decrease) in cash and cash equivalents
 
6,453
 
(6,856)
 
4,364
Cash and cash equivalents at beginning of year
 
5,690
 
12,546
 
8,182
Cash and cash equivalents at end of year
 
$12,143
 
$5,690
 
$12,546
             
             
See notes to condensed financial statements
           
             
Note to Condensed Financial Statements--Basis of Presentation The Company's investment in subsidiaries is stated at cost plus equity in the undistributed earnings of subsidiaries since the date of acquisition. The Company's share of net income of its subsidiaries is included in income using the equity method. These financial statements should be read in conjunction with the Company's consolidated financial statements.